Cargando…
Inhibition of ISG15 Enhances the Anti-Cancer Effect of Trametinib in Colon Cancer Cells
BACKGROUND: Colon cancer is one of the most common cancers worldwide. IFN-stimulated gene 15 (ISG15), a ubiquitin-like molecule, is strongly up-regulated by type I interferon as a crucial response to a variety of microbial and cellular stress stimuli. However, the role of ISG15 in colon cancer remai...
Autores principales: | Zhou, Sheng, Ren, Meilin, Xu, Huanji, Xia, Hongwei, Tang, Qiulin, Liu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884973/ https://www.ncbi.nlm.nih.gov/pubmed/32063716 http://dx.doi.org/10.2147/OTT.S226395 |
Ejemplares similares
-
ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells
por: Zhou, Sheng, et al.
Publicado: (2018) -
Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer
por: Xu, Huanji, et al.
Publicado: (2021) -
Targeting SERT promotes tryptophan metabolism: mechanisms and implications in colon cancer treatment
por: Ye, Di, et al.
Publicado: (2021) -
MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells
por: Xu, Huanji, et al.
Publicado: (2019) -
ISG15: It's Complicated
por: Dzimianski, John V., et al.
Publicado: (2019)